OBJECTIVES: Despite treatment-related improvements in morbidity and mortality, HIV-1-infected (HIV+) individuals continue to face a wide range of HIV-associated medical and HIV-associated neurocognitive disorders. Little is known about the impact of cognitive impairment on patients' health-related quality of life (HRQoL). To address this, the current study examined the longitudinal relationship between cognitive functioning and HRQoL among HIV+ individuals. METHOD: The sample consisted of 1,306 HIV+ men enrolled in the Multicenter AIDS Cohort Study. Participants received biannual assessments of cognitive functioning (including tests of processing speed, executive functioning, attention/working memory, motor functioning, learning, and memory) and completed questionnaires assessing HRQoL and depression. Multilevel models were used to examine the longitudinal and cross-lagged relationship between HRQoL and cognition, independent of depression and HIV disease severity. RESULTS: There was a significant relationship between HRQoL and cognitive functioning both between and within subjects. Specifically, individuals who reported better HRQoL reported better cognitive functioning, and longitudinal change in cognition was positively related to change in HRQoL. There was a significant unidirectional-lagged relationship; cognition predicted HRQoL at subsequent visits, but HRQoL did not predict cognitive functioning at subsequent visits. Furthermore, analyses of severity of neurocognitive impairment revealed that transition to a more severe stage of cognitive impairment was associated with a decline in HRQoL. CONCLUSIONS: Overall, the current study suggests that changes in HRQoL are partially driven by changes in cognitive functioning. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
OBJECTIVES: Despite treatment-related improvements in morbidity and mortality, HIV-1-infected (HIV+) individuals continue to face a wide range of HIV-associated medical and HIV-associated neurocognitive disorders. Little is known about the impact of cognitive impairment on patients' health-related quality of life (HRQoL). To address this, the current study examined the longitudinal relationship between cognitive functioning and HRQoL among HIV+ individuals. METHOD: The sample consisted of 1,306 HIV+ men enrolled in the Multicenter AIDS Cohort Study. Participants received biannual assessments of cognitive functioning (including tests of processing speed, executive functioning, attention/working memory, motor functioning, learning, and memory) and completed questionnaires assessing HRQoL and depression. Multilevel models were used to examine the longitudinal and cross-lagged relationship between HRQoL and cognition, independent of depression and HIV disease severity. RESULTS: There was a significant relationship between HRQoL and cognitive functioning both between and within subjects. Specifically, individuals who reported better HRQoL reported better cognitive functioning, and longitudinal change in cognition was positively related to change in HRQoL. There was a significant unidirectional-lagged relationship; cognition predicted HRQoL at subsequent visits, but HRQoL did not predict cognitive functioning at subsequent visits. Furthermore, analyses of severity of neurocognitive impairment revealed that transition to a more severe stage of cognitive impairment was associated with a decline in HRQoL. CONCLUSIONS: Overall, the current study suggests that changes in HRQoL are partially driven by changes in cognitive functioning. (PsycINFO Database Record (c) 2019 APA, all rights reserved).
Authors: T González-Salvador; C G Lyketsos; A Baker; L Hovanec; C Roques; J Brandt; C Steele Journal: Int J Geriatr Psychiatry Date: 2000-02 Impact factor: 3.485
Authors: E G Bing; R D Hays; L P Jacobson; B Chen; S J Gange; N E Kass; J S Chmiel; S L Zucconi Journal: Qual Life Res Date: 2000-02 Impact factor: 4.147
Authors: R D Hays; W E Cunningham; C D Sherbourne; I B Wilson; A W Wu; P D Cleary; D F McCaffrey; J A Fleishman; S Crystal; R Collins; F Eggan; M F Shapiro; S A Bozzette Journal: Am J Med Date: 2000-06-15 Impact factor: 4.965
Authors: V Tozzi; P Balestra; R Murri; S Galgani; R Bellagamba; P Narciso; A Antinori; M Giulianelli; G Tosi; M Fantoni; A Sampaolesi; P Noto; G Ippolito; A W Wu Journal: Int J STD AIDS Date: 2004-04 Impact factor: 1.359
Authors: David Tate; Robert H Paul; Timothy P Flanigan; Karen Tashima; Justin Nash; Christine Adair; Robert Boland; Ronald A Cohen Journal: AIDS Patient Care STDS Date: 2003-03 Impact factor: 5.078
Authors: Steven M Asch; Amy M Kilbourne; Allen L Gifford; M Audrey Burnam; Barbara Turner; Martin F Shapiro; Samuel A Bozzette Journal: J Gen Intern Med Date: 2003-06 Impact factor: 5.128
Authors: Laura Cheney; Hillary Guzik; Frank P Macaluso; Fernando Macian; Ana Maria Cuervo; Joan W Berman Journal: Cells Date: 2020-06-09 Impact factor: 6.600
Authors: Georgette D Kanmogne; Julius Y Fonsah; Anya Umlauf; Jacob Moul; Roland F Doh; Anne M Kengne; Bin Tang; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Donald Franklin; Dora M Njamnshi; Callixte T Kuate; Dora Mbanya; Alfred K Njamnshi; Robert K Heaton Journal: Sci Rep Date: 2020-08-20 Impact factor: 4.379
Authors: Emily W Paolillo; Elizabeth C Pasipanodya; Raeanne C Moore; Brian W Pence; Joseph Hampton Atkinson; David J Grelotti; Igor Grant; Robert K Heaton; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2020-07-01 Impact factor: 3.731
Authors: Ni Sun-Suslow; Emily W Paolillo; Erin E Morgan; Scott Letendre; Jennifer Iudicello; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2020-08-15 Impact factor: 3.731